Structure-Based Design and Synthesis of Highly Potent SARS-CoV 3CL Protease Inhibitors-Reference-Cited by-同舟云学术

Structure-Based Design and Synthesis of Highly Potent SARS-CoV 3CL Protease Inhibitors

Published:2007-09-24 Issue:14 Volume:8 Page:1654-1657
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

Shao Yi-Ming,Yang Wen-Bin,Peng Hung-Pin,Hsu Min-Feng,Tsai Keng-Chang,Kuo Tun-Hsun,Wang Andrew H.-J.,Liang Po-Huang,Lin Chun-Hung,Yang An-Suei,Wong Chi-Huey

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cbic.200700254/fullpdf

Reference22 articles.

1. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

2. SARS — beginning to understand a new virus

3. Mechanisms and enzymes involved in SARS coronavirus genome expression

4. Structural insights into SARS coronavirus proteins

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review;European Journal of Medicinal Chemistry;2023-11

2. The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19;Antioxidants;2022-09-21

3. Perspectives on SARS-CoV-2 Main Protease Inhibitors;Journal of Medicinal Chemistry;2021-11-19

4. Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology;Topics in Current Chemistry;2021-04-22

5. Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?;European Journal of Medicinal Chemistry;2021-04